Skip to main content

The FDA recently issued a warning letter to Allergan, the makers of eyelash-lengthening medication Latisse, stating that the company “omitted and minimized” certain risks in their advertising. Specifically, the warning is related to possible changes in lid and iris pigmentation, excess hair growth outside of the treated area, bacterial eye infections, and allergic reactions.

While we have not observed any significant complications in our patients, it is important to know that any topical treatment has the potential for irritations or allergic reaction.

The bottom line? Use as directed and contact your eye doctor if you experience pain or discharge, or have any concerns about changes in your eyes.